Medical Economics June 24, 2025
Key Takeaways
- LifeLeaf is a non-invasive, cuffless wearable device for continuous blood glucose and blood pressure monitoring, validated in multi-center clinical trials.
- The device demonstrated comparable accuracy to traditional invasive methods, with a mean absolute relative difference of 10.8% for glucose and minimal blood pressure measurement differences.
- LifeLeaf is 70% more cost-effective annually than existing solutions, offering a significant advancement in preventive care.
- The non-invasive, AI-powered technology aims to improve patient adherence and early disease detection, potentially transforming chronic disease management.
Product eliminates the need for needles, cuffs, and calibration.
LifePlus, a Silicon Valley health tech startup, announced the clinical validation of LifeLeaf, a breakthrough non-invasive, cuffless wearable device that enables continuous monitoring of blood glucose and blood...
Today's Sponsors
Today's Sponsor